FFA
SUPN icon

Farther Finance Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Farther Finance Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.4K Buy
242
+13
+6% +$593 ﹤0.01% 4594
2026
Q2 		$10.7K Sell
229
-54
-19% -$2.59K ﹤0.01% 4380
2026
Q1 		$14.6K Sell
283
-37
-12% -$1.88K ﹤0.01% 3867
2025
Q4 		$15.9K Buy
320
+212
+196% +$10.3K ﹤0.01% 3594
2025
Q3 		$5.16K Buy
108
+46
+74% +$1.85K ﹤0.01% 3757
2025
Q2 		$1.95K Sell
62
-90
-59% -$2.88K ﹤0.01% 3707
2025
Q1 		$4.82K Buy
152
+37
+32% +$1.31K ﹤0.01% 3081
2024
Q4 		$4.16K Sell
115
-20
-15% -$704 ﹤0.01% 2745
2024
Q3 		$4.21K Sell
135
-20
-13% -$624 ﹤0.01% 2714
2024
Q2 		$4.12K Buy
155
+61
+65% +$1.77K ﹤0.01% 2482
2024
Q1 		$3.15K Sell
94
-33
-26% -$983 ﹤0.01% 2291
2023
Q4 		$3.67K Buy
127
+57
+81% +$1.51K ﹤0.01% 2125
2023
Q3 		$1.93K Buy
70
+5
+8% +$152 ﹤0.01% 1869
2023
Q2 		$1.95K Hold
65
– – ﹤0.01% 1762
2023
Q1 		$2.35K Hold
65
– – ﹤0.01% 1580
2022
Q4 		$2.32K Buy
+65
New +$2.26K ﹤0.01% 1401

Other funds holding SUPN

JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Farther Finance Advisors's SUPN Position: Q3 2026 in Review

Farther Finance Advisors increased its Supernus Pharmaceuticals (SUPN) stake by 5.7% in Q3 2026, buying an estimated $593 and bringing the position to 242 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4594.

Farther Finance Advisors first reported a position in SUPN in Q4 2022 and has held it in 16 quarters since. The position peaked at $15.9K in Q4 2025. 8 funds tracked by Wall St. Rank hold SUPN as of Q3 2026.

  • Farther Finance Advisors held 242 shares of Supernus Pharmaceuticals worth $10.4K as of Q3 2026.
  • Farther Finance Advisors bought 13 Supernus Pharmaceuticals shares in Q3 2026, an estimated $593.
  • Supernus Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4594 holding.
  • Farther Finance Advisors first reported a position in Supernus Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Supernus Pharmaceuticals position peaked at $15.9K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.